Economic analysis of bevacizumab, cetuximab, and panitumumab with fluoropyrimidine-based chemotherapy in the first-line treatment of KRAS wild-type metastatic colorectal cancer (mCRC)

✍ Scribed by Lawrence, Donna; Maschio, Michael; Leahy, Kevin J.; Yunger, Simon; Easaw, Jacob C.; Weinstein, Milton C.

• Book ID: 126473064
• Publisher: Informa plc
• Year: 2013
• Tongue: English
• Weight: 466 KB
• Volume: 16
• Category: Article
• ISSN: 1369-6998
• DOI: 10.3111/13696998.2013.852097